Morepen Labs.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE083A01026
NSEID: MOREPENLAB
BSEID: 500288

INR

40.83

2.09 (5.39%)

BSENSE

Dec 19

BSE+NSE Vol: 46.97 lacs

{
  "main_header": {
    "sid": 546345,
    "name": "Morepen Labs.",
    "stock_name": "Morepen Labs.",
    "full_name": "Morepen Laboratories Ltd",
    "name_url": "stocks-analysis/morepen-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "40.83",
    "chg": 2.09,
    "chgp": "5.39%",
    "dir": 1,
    "prev_price": "38.74",
    "mcapval": "2,199.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500288,
    "symbol": "MOREPENLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE083A01026",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "46.97 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/morepen-labs-546345-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Morepen Labs. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-morepen-labs-fallingrising-3764326",
        "imagepath": "",
        "date": "2025-12-20 02:26:24",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Morepen Laboratories’ share price increase on 19 December marks a significant rebound after a period of decline. The stock outperformed its sector by 4.64% on the day, reaching an intraday high of ₹41.45, a 7% rise from its previous close. This positive momentum follows four consecutive days of losses, signalling a potential short-term trend reversal. However, the stock remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating that the broader trend remains bearish.</p>\n<p>Investor participation has notably increased, with delivery volumes on 18 December surging by 145.56% to 15.25 lakh shares compared to the five-day average. This heightened activity suggests renewed interest..."
      },
      {
        "title": "Morepen Laboratories Stock Falls to 52-Week Low of Rs.39.32 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-stock-falls-to-52-week-low-of-rs3932-3762294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLaborato_priceRelatedfactors_3762294.png",
        "date": "2025-12-18 09:51:17",
        "description": "Morepen Laboratories has reached a new 52-week low of Rs.39.32 today, marking a significant decline amid a sustained downward trend. The stock has been trading below all major moving averages and has recorded losses over the past four consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Morepen Laboratories Stock Falls to 52-Week Low of Rs.40 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-stock-hits-52-week-low-amidst-continued-downtrend-3761430",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLaborato_priceRelatedfactors_3761430.png",
        "date": "2025-12-17 14:47:23",
        "description": "Morepen Laboratories has reached a new 52-week low of Rs.40, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market valuation."
      },
      {
        "title": "Morepen Labs. Sees Revision in Market Assessment Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/morepen-labs-downgraded-to-strong-sell-amid-weak-financial-and-technical-trends-3759908",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLabs_mojoScore_3759908.png",
        "date": "2025-12-16 10:10:19",
        "description": "Morepen Labs., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent assessment highlights subdued financial performance and technical indicators that have influenced the stock’s current market perception."
      },
      {
        "title": "Morepen Laboratories Stock Falls to 52-Week Low of Rs.40.01 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-stock-falls-to-52-week-low-of-rs4001-3753575",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLaborato_priceRelatedfactors_3753575.png",
        "date": "2025-12-09 10:13:26",
        "description": "Morepen Laboratories has reached a new 52-week low of Rs.40.01, marking a significant decline amid a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market sentiment."
      },
      {
        "title": "Morepen Laboratories Stock Falls to 52-Week Low of Rs.41.33",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-stock-falls-to-52-week-low-of-rs4133-3751174",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLaborato_priceRelatedfactors_3751174.png",
        "date": "2025-12-08 10:53:21",
        "description": "Shares of Morepen Laboratories touched a fresh 52-week low of Rs.41.33 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock has been underperforming the Pharmaceuticals & Biotechnology sector and continues to trade below all major moving averages."
      },
      {
        "title": "Morepen Laboratories Stock Hits 52-Week Low at Rs.41.33 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-stock-falls-to-52-week-low-of-rs4133-3751172",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLaborato_priceRelatedfactors_3751172.png",
        "date": "2025-12-08 10:53:16",
        "description": "Morepen Laboratories has reached a new 52-week low of Rs.41.33, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over the past year."
      },
      {
        "title": "Morepen Laboratories Faces Challenging Market Conditions Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/morepen-laboratories-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3727841",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MorepenLaborato_mojoScore_3727841.png",
        "date": "2025-11-25 08:42:08",
        "description": "Morepen Laboratories, a player in the Pharmaceuticals & Biotechnology sector, is currently navigating a complex market environment marked by subdued financial results and cautious technical indicators. Recent shifts in evaluation metrics reflect a nuanced perspective on the company’s quality, valuation, financial trends, and technical outlook, underscoring the challenges it faces amid broader market dynamics."
      },
      {
        "title": "How has been the historical performance of Morepen Labs.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-morepen-labs-3726354",
        "imagepath": "",
        "date": "2025-11-24 23:14:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Morepen Labs’ net sales have shown a consistent upward trend, increasing from ₹768.54 crores in March 2019 to ₹1,811.58 crores in March 2025. This represents a more than twofold increase over six years, reflecting the company’s expanding market presence and product portfolio. Despite a slight dip in sales in March 2022 compared to the previous year, the overall trajectory remains positive.</p>\n<p>Operating profit before depreciation and interest (PBDIT) excluding other income rose from ₹67.52 crores in 2019 to ₹174.07 crores in 2025, indicating improved operational efficiency. Including other income, operating profit increased to ₹192.43 crores in the latest fiscal year. Profit after tax (PAT) also followed a similar pattern, climbing from ₹28.84 cro..."
      }
    ],
    "total": 354,
    "sid": "546345",
    "stock_news_url": "https://www.marketsmojo.com/news/morepen-laboratories-546345"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 (LODR)",
      "datetime": "04-Dec-2025",
      "details": "Disclosure under Regulation 30 (LODR)",
      "source": "BSE"
    },
    {
      "caption": "Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window",
      "datetime": "01-Dec-2025",
      "details": "Please find attached the report for the month of November 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "Newspaper Publication-Financial Results for the quarter and half year ended September 30 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Morepen Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 29 Aug 25",
          "dt": "2025-08-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Morepen Labs. falling/rising?

2025-12-20 02:26:24

Recent Price Movement and Market Context

Morepen Laboratories’ share price increase on 19 December marks a significant rebound after a period of decline. The stock outperformed its sector by 4.64% on the day, reaching an intraday high of ₹41.45, a 7% rise from its previous close. This positive momentum follows four consecutive days of losses, signalling a potential short-term trend reversal. However, the stock remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating that the broader trend remains bearish.

Investor participation has notably increased, with delivery volumes on 18 December surging by 145.56% to 15.25 lakh shares compared to the five-day average. This heightened activity suggests renewed interest...

Morepen Laboratories Stock Falls to 52-Week Low of Rs.39.32 Amidst Prolonged Downtrend

2025-12-18 09:51:17

Morepen Laboratories has reached a new 52-week low of Rs.39.32 today, marking a significant decline amid a sustained downward trend. The stock has been trading below all major moving averages and has recorded losses over the past four consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Morepen Laboratories Stock Falls to 52-Week Low of Rs.40 Amidst Prolonged Downtrend

2025-12-17 14:47:23

Morepen Laboratories has reached a new 52-week low of Rs.40, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market valuation.

Morepen Labs. Sees Revision in Market Assessment Amidst Challenging Financial Trends

2025-12-16 10:10:19

Morepen Labs., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent assessment highlights subdued financial performance and technical indicators that have influenced the stock’s current market perception.

Morepen Laboratories Stock Falls to 52-Week Low of Rs.40.01 Amidst Prolonged Downtrend

2025-12-09 10:13:26

Morepen Laboratories has reached a new 52-week low of Rs.40.01, marking a significant decline amid a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market sentiment.

Morepen Laboratories Stock Falls to 52-Week Low of Rs.41.33

2025-12-08 10:53:21

Shares of Morepen Laboratories touched a fresh 52-week low of Rs.41.33 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock has been underperforming the Pharmaceuticals & Biotechnology sector and continues to trade below all major moving averages.

Morepen Laboratories Stock Hits 52-Week Low at Rs.41.33 Amidst Prolonged Downtrend

2025-12-08 10:53:16

Morepen Laboratories has reached a new 52-week low of Rs.41.33, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over the past year.

Morepen Laboratories Faces Challenging Market Conditions Amid Mixed Financial and Technical Signals

2025-11-25 08:42:08

Morepen Laboratories, a player in the Pharmaceuticals & Biotechnology sector, is currently navigating a complex market environment marked by subdued financial results and cautious technical indicators. Recent shifts in evaluation metrics reflect a nuanced perspective on the company’s quality, valuation, financial trends, and technical outlook, underscoring the challenges it faces amid broader market dynamics.

How has been the historical performance of Morepen Labs.?

2025-11-24 23:14:10

Revenue and Profit Growth

Morepen Labs’ net sales have shown a consistent upward trend, increasing from ₹768.54 crores in March 2019 to ₹1,811.58 crores in March 2025. This represents a more than twofold increase over six years, reflecting the company’s expanding market presence and product portfolio. Despite a slight dip in sales in March 2022 compared to the previous year, the overall trajectory remains positive.

Operating profit before depreciation and interest (PBDIT) excluding other income rose from ₹67.52 crores in 2019 to ₹174.07 crores in 2025, indicating improved operational efficiency. Including other income, operating profit increased to ₹192.43 crores in the latest fiscal year. Profit after tax (PAT) also followed a similar pattern, climbing from ₹28.84 cro...

View All News